by Aaron E. | Jul 19, 2024 | Market News
Introduction Cassava Sciences Inc. (NASDAQ: SAVA) is a biotechnology company at the forefront of developing innovative treatments for neurodegenerative diseases, most notably Alzheimer’s disease. With its lead therapeutic product candidate, Simufilam, Cassava...
by Aaron E. | Jul 16, 2024 | Market News
Introduction Citius Pharmaceuticals Inc. (NASDAQ: CTXR) is a biopharmaceutical company dedicated to developing and commercializing critical care products, focusing on oncology, anti-infectives, and stem cell therapy. With a significant catalyst approaching—the PDUFA...
